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In vitro studies were performed to characterize the vaccine strain, designated PlOO, 
derived from the arthrogenic reovirus isolate, S1133, by cold adaptation. PlOO appeared 
to be temperature sensitive, shown by a marked drop in titer and efficiency of plaquing 
after incubation at 41°. Studies indicated that genomic double-stranded RNA and protein 
synthesis were severely restricted at the elevated temperature. Differences in the growth 
behavior of PlOO and S1133 at 37” were also noted. The vaccine strain seemed to be more 
cell associated than S1133. Three outer coat proteins of PlOO grown at 3’7” displayed 
mobilities different from those of 51133 by PAGE. It is possible that alterations in these 
proteins may have some relationship to the growth characteristics observed for the PlOO 
strain. 
INTRODUCTION 
Reoviruses are ubiquitous in nature, 
possessing a wide range of hosts including 
man, numerous other mammals, and do- 
mestic birds (Ramig and Fields, 1977). The 
avian reoviruses comprise a serologically 
distinct group that can be differentiated 
further from the mammalian reoviruses 
by their lack of a hemagglutinin, different 
host range, and ability to fuse cells in cul- 
ture (Olson, 1978). Moreover, unlike the 
mammalian reoviruses, avian reoviruses 
have been naturally associated with a va- 
riety of diseases including viral arthritis 
and tenosynovitis, gastroenteritis, hepa- 
titis, myocarditis, and respiratory illness 
in chickens (van der Heide, 1980) and in- 
fectious enteritis in turkeys (Gershowitz 
and Wooley, 1973). 
Viral arthritis in chickens, first recog- 
nized in 1959 (Olson, 1959), has since re- 
ceived great attention from researchers in 
the poultry industry. The disease, al- 
though associated with low mortality, of- 
ten produces high morbidity rates result- 
ing in significant economic losses (Glass et 
CLZ., 1973; Olson and Solomon, 1968) and 
’ To whom reprint requests should be directed. 
therefore attempts have been made to pro- 
duce a vaccine suitable for young chicks. 
Continued in vitro propagation at 31’ of 
an extremely virulent and arthrogenic iso- 
late, S1133, was performed and the re- 
sulting pools were tested at various levels 
of passage for efficacy in terms of immu- 
nogenicity and protection afforded upon 
challenge with wild-type virus (Rau et cd., 
1980; van der Heide, 1975; van der Heide, 
1980). A vaccine has been produced from 
the 100th passage virus pool and desig- 
nated “PlOO.” Pathogenicity of PlOO, when 
given by different routes of inoculation and 
at various doses to day-old chicks, has been 
studied and compared to the parent S1133 
(Gouvea and Schnitzer, 1982). 
The conditions under which strain S1133 
was serially propagated in order to obtain 
PlOO were those of “cold-adaptation.” 
However, the manner in which PlOO dif- 
fers from the parental S1133 has not been 
examined in vitro. The relative ability of 
PlOO to grow at either low or high tem- 
perature has not been evaluated nor have 
any biochemical studies looked for alter- 
ations in viral proteins or genes. The aim 
of this study was to undertake an initial 
in vitro characterization in biological and 
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biochemical terms of the vaccine strain 
PlOO in an attempt to detect differences 
from the parent S1133. Further exami- 
nation of such alterations could then help 
identify genetic and biochemical markers 
that may be useful for studies on factors 
related to viral virulence in chickens. 
MATERIALS AND METHODS 
Cells. Chick embryo fibroblasts (CEF) 
and chick embryo liver cultures (CELi) 
were prepared from lo- and 14-day-old 
embryos, respectively, by conventional tis- 
sue culture techniques. CEF cells were 
grown in Dulbecco’s modified essential 
medium (DMEM) supplemented with 5% 
tryptose phosphate broth, 2% newborn calf 
serum (NCS), and 2% chick serum. The 
first and second passages of CEF grown in 
the same medium were used for virus 
propagation. CELi cultures were prepared 
in DMEM supplemented with 10% NCS 
and used within 48 to 72 hr. 
Viruses. The 73rd chorioallantoic mem- 
brane (CAM) passage of strain S1133 of 
avian reovirus, originally isolated during 
an outbreak of severe tenosynovitis in 
Connecticut, and its attenuated vaccine 
strain PlOO (van der Heide, 1975, 1980) 
were kindly supplied by Dr. L. van der 
Heide (Department of Pathobiology, Uni- 
versity of Connecticut, Storrs). The PlOO 
virus had been produced by 235 passages 
in CAM followed by an additional 100 pas- 
sages in CEF, 40 of which were at low tem- 
perature (32”) (L. van der Heide, personal 
communication). Both S1133 and PlOO vi- 
ruses were plaque-purified three times in 
CEF and a final pool was made and ti- 
trated to be used in all assays. 
Virus titration, CEF or CELi monolay- 
ers grown in six-well plastic plates were 
infected with 0.5 ml/well of a series of lo- 
fold dilutions of virus suspension in phos- 
phate-buffered saline (PBS) and virus al- 
lowed to absorb at 37” for 1 hr. The in- 
oculum was then removed and the cells 
were washed twice with PBS. Two milli- 
liters of overlay medium (1.5% agarose, 
2% NCS in minimum essential (MEM)) 
was added per well and plates were in- 
cubated at 37”. When plaques could be eas- 
ily detected, after 2 days (CELi) or 4 days 
(CEF), 1 ml of a second overlay (0.9% aga- 
rose, 0.005% neutral red in MEM) was 
added per well. Plates were incubated at 
37” and plaques were counted on the 
next day. 
Eflciency of plaquing (EOP) at 33 and 
41”. Determination of the ability of the 
viruses to produce plaques at high and low 
temperatures was done as described above 
for virus titration, except that after ad- 
sorption at 37”, plates were incubated at 
33, 37, or 41” accordingly. 
Propagation and protein labeling of ui- 
ruses. Confluent monolayers of CEF cells 
in 90-mm plates were infected with 0.5 ml 
of virus suspension at a multiplicity of in- 
fection (m.o.i.) of approximately 1, and in- 
cubated at 37” for 1 hr. After virus ad- 
sorption, the inoculum was removed, 5 ml 
of DMEM-2% NCS was added per plate, 
and the plates were returned to 37”. When 
CPE became evident, but infected cells 
were still attached to the plate, the me- 
dium was replaced with DMEM containing 
5% the normal amount of methionine and 
2% dialyzed NCS. Then 100 &i of 
[35S]methionine (Amersham, 400-800 Ci/ 
mol) was added per plate and virus mul- 
tiplication allowed to proceed at 37”. At 
maximum CPE, usually 48 hr postinfec- 
tion (p.i.), infected cultures were har- 
vested and either frozen at -70” or im- 
mediately processed for virus purification. 
PurQication of virus. Cellular and su- 
pernatant fractions from infected cultures 
were separated by low-speed centrifuga- 
tion. Virus was recovered from the super- 
natant by pelleting, pooled with cellular 
fraction, extracted with Freon, and puri- 
fied by CsCl gradient centrifugation as 
previously described (Schnitzer et al, 1982). 
Radiolabeling and immune precipitation 
of viral proteins in cell e&w&. CEF cells 
in 60-mm plates were infected at a m.o.i. 
of 10 PFU/cell as described above and in- 
cubated either at 37 or 41”. At various 
times after adsorption, metabolic labeling 
was done by replacing the medium with 
methionine-free medium containing 2% 
dialyzed NCS and supplemented with 25 
&i of [?S]methionine/ml. After a 3-hr 
pulse, a cellular extract was prepared and 
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viral polypeptides were immunoprecipi- 
tated as previously described (Schnitzer et 
al., 1982). 
Radiolabeling of cytoplasmic dsRNA. 
CEF monolayers in 50-mm plates were in- 
fected at a m.o.i. of 10 PFU/cell and in- 
cubated at 37” for 1 hr. After adsorption 
the inoculum was removed and 3 ml of 
DMEM containing 2% dialyzed NCS, 60 
pg/ml actinomycin D (Act. D), and 30 &i 
[5-6-3H]uridine (Amersham) were added 
per plate and the plates incubated either 
at 3’7 or 41” in a 5% COz atmosphere. At 
18 hr postinfection the cells were har- 
vested and separated from the superna- 
tant by low-speed centrifugation. Virus 
was pelleted from the supernatant by cen- 
trifugation at 50,000 g for 90 min and sol- 
ubilized in Laemmli’s sample buffer. Cy- 
toplasmic double-stranded RNA (dsRNA) 
and cell-associated virus in the cellular 
fraction were dissolved in Laemmli’s sam- 
ple buffer. 
Polyacrylamide gel electrophoresis. Elec- 
trophoresis was carried out in 9% acryl- 
amide-0.267% bis-acrylamide slab gels in 
a discontinuous Tris-glycine buffer sys- 
tem. Samples were boiled for 1 min prior 
to loading onto gels, and electrophoresis 
proceeded at 140 V for 15 hr (dsRNA) or 
at 200 V for 4 hr (proteins). After the run, 
gels were fixed and processed for autora- 
diography as previously described (Gou- 
vea and Schnitzer, 1982) or silver stained 
as described by Sammons et al. (1981). 
RESULTS 
Growth characteristics. Representative 
growth curves of virus strains S1133 and 
PlOO incubated at 33, 37, and 41” in CEF 
cells are shown in Fig. 1. It can be seen 
that S1133 replicated well at all three tem- 
peratures, with peak virus production oc- 
curring at 18 hr p.i. The PlOO strain yielded 
titers similar to those of S1133 after in- 
cubation at 37”, while appearing to gen- 
erate slightly more progeny than S1133 at 
33”. However, in marked contrast to S1133, 
PlOO seemed unable to multiply at 41”. The 
efficiency of plating (EOP) of both viral 
strains at 33 and 41” was determined 
(Table l), demonstrating that PlOO had 
also acquired a temperature-sensitive (ts) 
characteristic in the process of becoming 
cold adapted. At either 33 or 37”, the plaque 
morphologies of both strains were indis- 
tinguishable. Both viruses produced ex- 
tensive syncytia with complete destruc- 
tion of the monolayer, although the syn- 
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FIG. 1. Growth curves of S1133 and PlO6 at 33, 37, and 41”. CEF monolayers in 30-mm plates 
were infected at an m.o.i. of 2 PFWcell. After virus adsorption for 1 hr at 3’7”, the cells were 
washed twice with PBS and 2 ml of DMEM-2% NCS was added. Plates were incubated at 33, 37, 
or 41”. Every 6 hr duplicate plates were withdrawn from each incubator, submitted to three cycles 
of freeze-thawing, and the culture suspensions were titrated in CELi monolayers incubated at 37’. 
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TABLE 1 
EFFICIENCY OF PLAQUING (EOP) AT 33 AND 41” 
Virus titer 
(log,, (PFU/ml))” 
Virus Cells 33” 37” 41” 
s1133 CEF 6.3 7.2 6.9 
CELi 6.8 7.8 6.8 
PlOO CEF 7.0 6.5 <2.0 
CELi 7.9 7.5 <2.0 
“Numbers represent the mean of titers obtained 
in 3 experiments. 
cytia in S1133-infected cultures were often 
significantly larger than those obtained in 
PlOO-infected cultures. 
Another difference in the behavior of the 
two strains is emphasized in Table 2. Viral 
titers obtained at various times after in- 
fection from the supernatant of either 
S1133- or PlOO-infected cells or from the 
harvested cell monolayers themselves sug- 
gested that PlOO particles may be more 
cell associated than S1133 particles. The 
titers show that up to 24 hr p.i. the yields 
of the parent strain, S1133, from the su- 
pernatant and the cells follow a similar 
distribution to that seen in the PlOO-in- 
fected cultures with approximately lOO- 
fold more virus being found in the cellular 
fraction than in the supernatant. How- 
ever, by 37 hr p.i. and after, this pattern 
was changed. In the S1133-infected cul- 
VACCINE STRAIN 243 
tures, roughly equal amounts of virus were 
shed into the supernatant as were found 
in the cellular portion of the cultures; in 
the PlOO infections, lOO- to lOOO-fold more 
virus was recovered from the cell mono- 
layers than from the supernatant. 
Synthesis of genomic &RNA. Although 
the PlOO strain seemed unable to form in- 
fectious progeny at 41°, it was of interest 
to determine whether any phase of viral 
replication was taking place within the 
host cells at the restrictive temperature. 
CEF cultures infected with PlOO in the 
presence of Act. D were incubated at 41” 
and labeled with rH]uridine to see if any 
genomic dsRNA was synthesized. The au- 
toradiogram in Fig. 2 shows that PlOO seg- 
ments are not present in infected cell ly- 
sates after incubation at the restrictive 
temperature. By subjecting the gel to the 
more sensitive assay of silver staining, 
faint bands could be detected which mi- 
grated parallel to the genomic segments 
synthesized during a productive infection 
(data not shown). These data indicate that 
a very limited level of PlOO replication may 
take place at the nonpermissive temper- 
ature, although the infection is largely in- 
hibited. 
The dsRNA segments extracted from 
supernatant or cell monolayers infected 
with PlOO at 37” migrated identically to 
those of S1133 analyzed in a similar man- 
ner (Fig. 2). There was no evidence of ei- 
ther smaller genomic fragments or dele- 
TABLE 2 
TITERS OF PlOO AND S1133 OBTAINED FROM SIJPERNATANT AND CELLULAR FRACTIONS 
OF INFECTED CULTURES INCUBATED AT 37”” 
22133 Ploo 
PFWml PFU/ml Total PFU/ml PFU/ml Total 
hr p.i. supernatant cells PFU/ml supernatant cells PFU/ml 
2 2.3b 2.6 2.8 2.9 <2.0 2.9 
7 2.3 2.6 2.8 2.9 <2.0 2.9 
12 2.7 4.6 4.6 2.0 2.3 2.4 
18 2.9 5.0 5.0 2.0 3.4 3.4 
24 4.3 6.0 6.0 2.6 4.0 4.0 
37 6.8 7.7 7.8 4.0 7.0 7.0 
42 8.0 7.7 8.1 4.1 7.0 7.0 
52 7.3 7.0 7.5 5.7 7.3 7.3 
a Supernatant fractions refer to medium alone before the monolayer was harvested. The monolayer was 
then subjected to 3 cycles of freeze-thawing before sonieation. Infection was initiated at an m.o.i. of 2-5. 
b Numbers are expressed as log,, PFU/ml. 









FIG. 2. [3H]Uridine-labeled dsRNA of 51133 and PlOO. Supernatant virus dsRNA of S1133 produced 
at 37 (A) and 41” (B), and of PlOO produced at 3’7 (C) and 41” (D). Cytoplasmic and cell-associated 
viral dsRNA from cellular fraction of S1133-infected cells synthesized at 37 (E) and 41” (F), and 
of PlOO-infected cells synthesized at 37 (G) and 41” (H). 
tion of entire genome segments to suggest 
DI particle formation during infection. 
Similar results were seen after S1133 in- 
fection at either 37 or 41”. In addition, 
there was no detectable difference in the 
mobilities of the S1133 or PlOO segments, 
an observation which has been previously 
reported (Gouvea and Schnitzer, 1982). 
Synthesis of viral proteins. Infection with 
the PlOO strain at 41” was also examined 
for any evidence of viral protein synthesis. 
Cultures were pulse-labeled with [““S]- 
methionine at various times after infec- 
tion. At the end of the labeling period, cell 
lysates were prepared and proteins im- 
mune-precipitated to determine which, if 
any, viral proteins could be synthesized at 
the nonpermissive temperature. Figure 3 
depicts the results of one such experiment. 
The gel patterns indicate that only trace 
amounts of some of the proteins of PlOO 
are synthesized after incubation at 41” in 
comparison to the profile seen after growth 
at 37”. Although only proteins j‘s, (TA, and 
cc appear most clearly, it is not possible 
to say that the other proteins are not being 
produced. It can be noted that all the S1133 
proteins are present in large quantities af- 
ter infection at either 37 or 41”. Results 
similar to those obtained from infected 
ABCDEF 
FIG. 3. Autoradiogram of [asS]methionine-labeled 
polypeptides of S1133 and PlOO. Cell extracts from 
S1133-infected cells incubated at 37 (A) and at 41” 
(B), and of PlOO-infected cells incubated at 37 (E) 
and at 41” (F) were pulse-labeled (3 hr) at 12 hr p.i. 
and subjected to immune precipitation. Comparison 
was made with CsCl-purified S1133 (C) and PlOO (D) 
CEF cultures are seen when Vero cells are viruses. 
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FIG. 4. Autoradiogram of [35S]methionine-labeled 
structural polypeptides of S1133 and PlOO-purified 
viruses. Note the additional S1133 polypeptide (TB, a 
degradation product of polypeptide cs. 
infected with S1133 or PlOO at either tem- 
perature (data not shown) suggesting that 
the severe decrease in synthesis of PlOO 
polypeptides at 41” is not a host-cell-de- 
pendent phenomenon. 
Cmpatim of the polgpeptides of S1133 
and PlOO strains. When the proteins of 
PlOO and S1133 are examined by PAGE, 
it can be seen that at least two polypep- 
tides of PlOO have mobilities which differ 
from those of the parental S1133 (Figs. 3 
and 4). The major p polypeptide, ps, ap- 
peared to have a slightly slower migration, 
while a minor c protein, uc, ran well ahead 
of the S1133 cc. Both these avian reovirus 
polypeptides have been identified as outer 
capsid proteins (Schnitzer et aL, 1982). In 
addition, repeated examination of the pro- 
teins of the same preparation of purified 
S1133 revealed that upon prolonged stor- 
age or repeated freeze-thawing cycles, 
there was a gradual degradation of the us 
polypeptide yielding a new, lower-molec- 
ular-weight protein C+ (Fig. 4). This oc- 
curred repeatedly with several different 
preparations of S1133. However, prepa- 
rations of purified PlOO, treated in the same 
manner, seldom generated this fragment, 
and when us was seen it appeared in much 
lesser proportions than the us of S1133. 
The other PlOO proteins appeared identi- 
cal to those of S1133. 
DISCUSSION 
The data presented show that the avian 
reovirus vaccine strain, PlOO, has acquired 
some growth characteristics which are not 
seen in its parental strain, S1133. In the 
process of becoming cold-adapted, PlOO has 
also become temperature sensitive at 41”, 
demonstrated by the inability of the virus 
to multiply or plaque at this temperature. 
Although cold adaptation and tempera- 
ture sensitivity are independent proper- 
ties, as has been shown with many chem- 
ically mutagenized viruses, it is not un- 
common for viruses adapted to grow at a 
lower temperature to simultaneously ac- 
quire the ts characteristic (Maassab et al, 
1981). 
The analysis of the growth behavior and 
synthesis of viral genome and proteins in- 
dicates that S1133 grows equally well at 
normal (3’7’) and “restrictive” tempera- 
tures (41”). However, the PlOO strain ap- 
pears severely limited in its ability to rep- 
licate at the higher temperature. Minute 
amounts of genomic dsRNA were detect- 
able only by silver staining and not by au- 
toradiography, and only trace amounts of, 
at most, three viral proteins could be found 
by immunoprecipitation after infection at 
41”. These observations would suggest that 
PlOO can enter the host cell and is pre- 
sumably uncoated, permitting initiation of 
viral replicative events and limited pro- 
tein synthesis. Amplification of viral rep- 
lication seems to be restricted afterward, 
evidenced by the low virus yields at the 
elevated temperature. It is not possible to 
determine which defective viral functions 
contribute to this inhibition. 
Acquisition of the t.s trait in numerous 
instances has occurred spontaneously, of- 
tentimes accompanied by a loss of viru- 
lence. PlOO has been demonstrated to be 
much less virulent for day-old chicks than 
S1133 (Gouvea and Schnitzer, 1982). Yet 
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the same experiments demonstrated that 
lack of virulence is not a reflection of de- 
creased infectivity. PlOO virus was still able 
to infect, spread, localize, and multiply in 
target tissues. It is worth noting that 41°, 
the in vitro restrictive temperature for 
PlOO virus, is the physiological tempera- 
ture of the chicken. It is possible, though, 
that sites with slightly lower body tem- 
perature would permit at least low levels 
of PlOO viral replication. Site-specific at- 
tenuation has been documented for infec- 
tions with ts mutants of influenza and re- 
spiratory syncytial virus (Murphy et al., 
1972; Wright et ak, 1971). 
Differences in behavior between PlOO 
and S1133 have also been noted at 37”. 
There is an indication that PlOO is not ca- 
pable of shutting off the host as well as 
the wild-type S1133 (unpublished results). 
Another interesting observation is that 
PlOO appears to remain cell associated at 
37” while S1133 particles are released. 
These functional changes could relate to 
the decreased pathogenicity of PlOO. 
Those factors responsible for the differ- 
ences seen between the parent and vaccine 
strain are not known. It has been shown 
in studies with the mammalian reoviruses 
that upon infection, virions enter cells 
where they are partially uncoated, trig- 
gering the activation of the endogenous 
transcriptase (Ramig and Fields, 1977; 
Spandidos and Graham, 1976). Uncoating 
or unmasking of the transcriptase is ini- 
tiated by the complete loss of polypeptides 
q and a3 and partial cleavage of plc (Jok- 
lik, 1981). Although correlations between 
the mammalian and avian reovirus poly- 
peptides have not yet been made conclu- 
sively, preliminary observations have led 
to assignments of the avian polypeptides 
uc, Q, and pa to polypeptides ul, u3, and 
plc of the mammalian reovirus, respec- 
tively (Schnitzer et aZ., 1982). It is of note 
that the uc, (TV, and pg proteins were found 
in PlOO to have altered mobility by PAGE 
(ac and pg) or altered stability (ua) when 
compared to homologous polypeptides of 
wild-type S1133 virus. It is possible that 
the alterations in these proteins may have 
contributed to the observations made in 
this study. 
Further work needs to be done to define 
with the avian reoviruses the functions of 
the individual genes and their respective 
protein products during viral replication. 
By the production and analysis of reas- 
sortant viruses, utilizing both PlOO and 
S1133 in combination with another appro- 
priately selected avian reovirus strain, it 
should be possible to determine which gene 
or genes of PlOO are important for both 
the biological as well as biochemical dif- 
ferences seen in comparison to S1133. Fur- 
thermore, in vitro hybridization analyses 
can directly examine gene alterations be- 
tween these two viruses. In this way, the 
mechanism behind the differences in be- 
havior of S1133 and PlOO at 37 and 41” 
might be determined, yielding better in- 
sights into the effects these strains exert 
on their host. 
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